Recent developments in optical molecular imaging allow for real-time identification of morphological and biochemical changes in tissue associated with gastrointestinal neoplasia. This review summarizes widefield and high resolution imaging modalities currently in pre-clinical and clinical evaluation for the detection of colorectal cancer and esophageal cancer. Widefield techniques discussed include high definition white light endoscopy, narrow band imaging, autofluoresence imaging, and chromoendoscopy; high resolution techniques discussed include probe-based confocal laser endomicroscopy, high-resolution microendoscopy, and optical coherence tomography. Finally, new approaches to enhance image contrast using vital dyes and molecular-specific targeted contrast agents are evaluated.
Introduction
reflux. Individuals with BE are at higher risk of developing precancerous lesions, which can progress to EAC. Because of this increased risk, it is recommended that individuals with BE undergo routine endoscopic examination at regular intervals to facilitate detection and treatment of precancers and early cancers. However, using standard, white light endoscopy it can be difficult to identify early neoplastic lesions. Thus, routine endoscopic surveillance of BE also includes random four-quadrant biopsies taken every 1-2 cm along the Barrett's segment [3, 4] .
Studies have shown that random four-quadrant biopsies can have miss rates up to 48% [8, 9] .
Furthermore, random four-quadrant biopsies taken every 2 cm can miss up to half of the cancers found when a protocol of 1 cm is used [10] .
Thus, there is an important need for new approaches that can improve the ability to identify early neoplastic lesions in the GI tract. This need has prompted the development of new optical imaging modalities to improve recognition and enable in vivo characterization of suspicious lesions in the GI tract. These approaches leverage both endogenous optical contrast as well as the use of contrast agents targeted against biomarkers that are associated with early neoplasia. This review summarizes recent advances in optical molecular imaging techniques to recognize early neoplastic disease in the GI tract. The paper first discusses new approaches that are in clinical evaluation; these approaches are based primarily on endogenous optical contrast and/or the use of vital dyes to enhance image contrast. The paper then describes approaches in development and preclinical evaluation, including the development of molecular-specific targeted contrast agents.
Clinical Studies
Several complementary widefield and high resolution imaging techniques are being evaluated to assist in the endoscopic detection and characterization of early neoplasia in the GI tract. Wide-field imaging modalities are designed to survey large areas of tissue, while high resolution imaging is limited to smaller fields of view but can achieve subcellular resolution. A variety of studies have been conducted to evaluate the performance of widefield imaging and high resolution imaging techniques in the clinical setting. An overview of these emerging technologies and the results of several recent clinical studies are provided in this section.
Widefield Imaging
With the development of high definition white light endoscopy (HD-WLE), the spatial resolution of standard white light endoscopy (WLE) has been drastically improved [11] . Narrow band imaging (NBI) is a complementary widefield technique that can assist in tissue characterization by enhancing the visibility of vasculature in the tissue via illumination with narrow bands of blue and green light, selected to match spectral regions with increased hemoglobin absorbance [12] . Neoplastic changes are often accompanied by an increase in microvasculature density. Hemoglobin is known to absorb wavelengths between 400-500 nm.
The visualization of microvasculature can therefore be enhanced by using optical filters to only pass two bands of illumination. Generally, green (530-550 nm) and blue (390-445 nm) wavelengths are used. The absorption of blue and green light by hemoglobin causes the vasculature to appear much darker than surrounding tissue without the need of a contrast agent.
Several clinical studies have been conducted to assess the effectiveness of NBI for detecting early neoplasia, but they have produced varying results. Some recent studies performed with the Olympus GIFQ240 have shown advantages of NBI as compared to HD-WLE [13, 14] . In a single center study involving 75 cites on 21 patients with BE, Singh et al.
compared diagnoses made with NBI and HD-WLE to histology results and found that the NBI diagnosis agreed with the histology results more often than HD-WLE (88.9% vs. 71.9%) [13] .
Muto et al. conducted a multicenter randomized trial comparing the detection rates of NBI and HD-WLE for early superficial esophageal squamous cell carcinoma (ESCC), a condition unrelated to BE. Of the 121 patients with histologically confirmed superficial ESCC, 63 patients with a total of 107 lesions were evaluated primarily with NBI followed by a secondary evaluation with HD-WLE, and the remaining 58 patients with a total of 105 lesions were evaluated primarily with HD-WLE followed by NBI. In the first group NBI alone detected 104 of the 107 lesions, while in the second group HD-WLE alone detected only 58 of the 105 lesions, yielding sensitivities of 97% and 55%, respectively. However, when the results of the secondary evaluations were considered, HD-WLE did not find any additional lesions in the first group, but the addition of NBI with HD-WLE in the second group increased the sensitivity to 95% [14] .
However, other recent studies performed with the Olympus H180 have indicated that the performance of NBI and HD-WLE are similar [15, 16] . Sharma et al. investigated the detection rate of intestinal metaplasia (IM) and neoplasia, the detection rate of neoplasia specifically, and the number of overall biopsies performed in 123 patients with BE for evaluations with NBI and HD-WLE. Half of the patients were randomly selected to receive HD-WLE examination, where biopsies of visible lesions were taken followed by random four quadrant biopsies for every 2 cm of the BE segment. The remaining patients received NBI examination, where biopsies were first taken of visible lesions, followed by targeted biopsies of areas detected by NBI. All patients returned within 3-8 weeks to receive the alternative procedure from a different endoscopist.
Both modalities identified 104 of 113 patients with intestinal metaplasia, demonstrating a detection rate of 92%. Patients that were missed by the first procedure were found to have IM in the subsequent procedure. NBI resulted in a total of 267 biopsies, while the standard 2 cm protocol resulted in 321 biopsies with HD-WLE. Histology was used to classify each biopsy as no IM, IM, low-grade dysplasia (LGD), high-grade dysplasia (HGD), or EAC. NBI did detect significantly more areas for any form of neoplasia, but when the analysis was limited to areas with HGD or EAC, there was no statistical difference between the two modalities. However, NBI did require fewer biopsies per patient (3.6 vs. 7.6, respectively) [16] . Pasha et al. analyzed a series of randomized controlled trials to determine the detection rate and miss rate for colon polyps and adenomas by NBI and HD-WLE. They evaluated six studies for the detection of adenomas and the detection of patients with polyps, four studies for the detection of patients with adenomas, and five studies for the detection of adenomas <10 mm, flat adenomas, and the number of flat adenomas per patient, and found no statistical difference in the performance of NBI and HD-WLE. They also found no statistical difference in the polyp miss rate (three studies) or adenoma miss rate (three studies) between the two modalities [17] .
Another widefield imaging technique, autofluorescence imaging (AFI), uses one wavelength of light to stimulate endogenous fluorophores in the tissue, triggering the emission of fluorescent light at longer wavelengths. The emitted light can be imaged on a charge-coupled device (CCD) using an emission filter to block scattered excitation light. Neoplasia is associated with changes in endogenous fluorescence; neoplastic epithelial cells are associated with increased fluorescence from mitochondrial co-factors NAD(P)H and FAD and collagen in the stroma near neoplastic lesions shows reduced fluorescence [18] . Like NBI, AFI does not require the application of a contrast agent. While studies have shown that AFI results in an increase in sensitivity for detection of early neoplasia in BE as compared to WLE, it has also demonstrated high false positive rates [19] [20] [21] [22] [23] . False positive rates as high as 40% have been reported using AFI for detection of early neoplasia in BE [19] . The high false positive rate of AFI is attributed to inflammation, which is also associated with loss of auto-fluorescence [20, 21] . Studies have indicated that when NBI is used in combination with AFI the false positive rate can be reduced, but in these studies NBI has misidentified high grade dysplasia as normal [19, 22] .
A recent study by Curvers et al. compared the performance of the endoscopic trimodal imaging (ETMI) system (Olympus GIFQ260FZ, available in Europe and Asia) to standard WLE.
The ETMI system can perform HD-WLE, AFI, and NBI. The study compared the detection rate of early neoplasia in Barrett's esophagus for each modality in 99 patients with low-grade intraepithelial neoplasia. All of the patients underwent two consecutive procedures with the ETMI (consisting of HD-WLE followed by AFI and NBI) and standard WLE in random order, each performed by two separate endoscopists with no particular expertise in BE or advanced imaging techniques. The endoscopist performing the second procedure was blinded to the results of the first procedure. Targeted biopsies were first taken from areas identified as suspicious, and the imaging modality that detected each suspicious area was noted. Four quadrant random biopsies every 2 cm were then taken. In Figure 1A through 1C, images from a patient with no lesions are shown for HD-WLE, AFI, and WLE, respectively. In Figure 1D and 1E, an early carcinoma is observed with HD-WLE and WLE, respectively. An additional lesion is visible via AFI, indicated by the yellow arrow in Figure 1G , which was not visible in the HD-WLE image of Figure 1F . The NBI image of Figure 1H shows suspicious abnormal blood vessels in the area of the lesion. This study found no significant difference in the overall (targeted + random) detection of dysplasia by ETMI versus standard WLE. There was no significant difference in the targeted detection of dysplastic lesions (low-grade intraepithelial neoplasia, high-grade intraepithelial neoplasia, or carcinoma) with HD-WLE detecting dysplasia in 23 patients as compared to 21 patients with standard WLE. However, the addition of AFI led to the detection of an additional 22 dysplastic lesions in 14 patients, increasing the number of detected patients from 21 to 35. NBI was associated with a decrease in the false positive rate, but was also associated with a reduction in sensitivity. Of the 24 patients with high grade intraepithelial neoplasia or carcinoma, random biopsies led to detection in only 6 patients evaluated with ETMI and 7 patients evaluated with standard WLE [23] . Other widefield imaging techniques have exploited contrast agents to enhance the visibility of neoplastic changes. Chromoendoscopy involves the use of stains, such as Lugol's iodine, to differentiate the areas of stratified squamous epithelium from areas of metaplasia associated with BE [12] . Ishimura et al. investigated the use of NBI and chromoendoscopy to assist in the detection of squamous islands for the diagnosis of short-segment BE, which is characterized by segments of metaplasia that are less than 2-3 cm in length. The number of identifiable squamous islands was documented first with HD-WLE, followed by NBI, and finally with chromoendoscopy, as shown in Figure 2A through 2C, respectively. Of the 100 patients evaluated in the study, squamous islands were visible in 48 of the patients using HD-WLE, 71 patients with NBI, and 75 patients with chromoendoscopy. NBI exhibited a detection rate of 94.7% as compared to chromoendoscopy. By contrast, HD-WLE demonstrated a detection rate of 64% when compared to chromoendoscopy. The mean number of detected squamous islands for HD-WLE, NBI, and chromoendoscopy was 0.55 ± 0.06, 1.02 ± 0.09, and 1.76 ± 0.18, respectively. While chromoendoscopy remains the most accurate way of visibly identifying squamous islands, NBI yielded comparable results without the risk of side effects from the use of Lugol's iodine [24] . 
High Resolution Imaging
High resolution imaging modalities can achieve sub-cellular resolution, albeit with small fields of view. This approach, which can provide an image similar to what is seen in histology, is often termed "optical biopsy". High resolution imaging is especially useful for targeting biopsies by providing a live image of the cellular architecture before the biopsy is taken [25] [26] [27] [28] .
There are a number of different high resolution imaging modalities currently being used in vivo; these include confocal laser endomicroscopy (CLE) [24] [25] [26] [27] and high resolution microendoscopy [34, 35] .
The main advantage of CLE over conventional microscopy is the use of a spatial filter to reject out-of-focus light, capturing preferentially from tissue located at the focal point of the imaging system. Because only the light from the focal plane of the system is captured, images can also be acquired at different depths. The typical resolution achievable with CLE is on the order of 1-2 microns with a field of view of approximately 500-700 μm 2 . CLE can be used either to image reflected light, or to image fluorescent light, typically with exogenous fluorescent contrast agents, such as fluorescein, acraflavine, and proflavine [24] [25] [26] 29, 31, 32] In practice, there are several variations of CLE that are used to acquire high resolution images. A commonly used type of CLE is probe-based confocal laser endomicroscopy (pCLE). diagnosed with high grade dysplasia or early carcinoma, HD-WLE alone missed 79 sites while the addition of pCLE reduced the number of missed sites to 38 [26] .
Wang et al. also employed pCLE to image the colon in vivo in a study of 54 patients.
Fluorescence images were acquired following the administration of fluorescein. After imaging, a pinch biopsy was also acquired at each site for histopathology. Image analysis was performed in this study to distinguish between normal mucosa, hyperplasia, tubular adenoma, and villous adenoma. Analysis of each image consisted of calculating the fluorescence contrast ratio which was defined as the ratio of the mean intensity of the lamina propria to the mean intensity of a crypt in a selected region of interest. Using the fluorescence contrast ratio, the study documented a sensitivity and specificity of 91% and 87%, respectively, when distinguishing between normal and lesional mucosa (including hyperplasia and adenomatous lesions). In addition, high sensitivities and specificities were found when distinguishing hyperplasia from adenoma (97% and 96%) and tubular adenoma from villous adenoma (100% and 92%) [31] .
Another use for high-resolution imaging is detecting neoplasia after therapy. Endoscopic mucosal resection (EMR) is generally considered appropriate for flat neoplastic lesions less than 1.5 cm in size that can be easily accessed by the endoscope [33] . High resolution imaging techniques can be useful in determining the perimeters for EMR, ensuring that all neoplastic areas have been removed. Shahid et al. evaluated the diagnostic accuracy of pCLE in detecting residual colorectal neoplasia after EMR in a prospective blind study of 92 patients. The goal was to compare pCLE to chromoendoscopy techniques such as NBI and to assess the diagnostic accuracy of the two modalities used together. Fluorescein was used as a contrast agent when performing pCLE. In the study, 92 patients had EMR's performed on a total of 129 sites. The EMR scars were imaged at all 129 sites. Histology determined that 29 sites had residual neoplasia. NBI was able to identify the residual neoplasias with a sensitivity and specificity of 72% and 78%, respectively while pCLE was reported to have sensitivity and specificity of 97% and 77%. When the two modalities were combined, a sensitivity and specificity of 100% and 87% was reported [25] .
High-resolution microendoscopy (HRME) is another fiber bundle based confocal technology that offers a portable, low-cost alternative to traditional confocal microendoscopy [34, 35] . Similar to pCLE, HRME acquires images by placing the fiber bundle in direct contact with the tissue surface. Instead of scanning through each optical fiber as with pCLE, each fiber in the bundle acts as an individual pixel which collectively forms a high resolution image that is comparable with other confocal microendoscopy techniques. HRME has been evaluated for use in a few studies for the GI tract [34, 35] . Additionally, it has been evaluated in a preliminary study in northern China. In this study, the performance of HRME was compared to the performance of chromoendoscopy using Lugol's iodine. Preliminary results have shown that even novice users can be trained to differentiate between normal, dysplastic, and neoplastic tissues with the HRME (http://www.youtube.com/watch?v=eJi28REXN_M).
Preclinical Development
In the preclinical setting, many groups are working to develop new contrast agents, including both vital dyes and molecular-targeted agents, to enhance widefield and high resolution imaging. Also, as imaging techniques have matured, there has been an increased focus on the co-registration of widefield molecular imaging and high resolution imaging. Some recent developments are highlighted below.
Widefield Imaging
While proflavine, a vital dye, has been primarily used clinically as a contrast agent to assist in high resolution imaging studies, shown in Figure 4 . The WGA contrast agent was able identify areas of dysplasia that would have otherwise been missed with normal WLE and AFI [36] . In an in vivo CPC;Apc mouse model study Miller et al. developed a fiber optic multispectral scanning endoscope designed to image multiple molecular targets simultaneously for use in early diagnosis of colorectal cancer. They identified three peptides (KCCFPAQ, AKPGYLS, LTTHYKL) that exhibited specific binding to colorectal adenomas and labeled them using fluorescence labels with minimal spectral overlap. Images acquired with the multispectral endoscope could be used to differentiate the emission spectra of two of these labels successfully, enabling simultaneous imaging of two molecular probes in vivo. Spatially distinguishable binding patterns were apparent during imaging, suggesting different binding targets for the peptides in dysplastic tissue.
However, the author indicates that further study into distinguishable dyes for molecular agents and algorithms to account for variations in tissue morphology and orientation are needed [37] .
High resolution imaging: increasing accuracy
One of the key limitations of high resolution imaging is the limited field of view.
Consequently, high resolution techniques sample only a small fraction of the mucosal surface at risk, presenting challenges especially in heterogeneous regions of tissue. Two techniques have been evaluated to overcome this limitation. One option is to couple the use of high resolution imaging with a widefield imaging system, employing the widefield system first to identify areas of suspicion, which can then be characterized by a high resolution system. Another technique recently developed is video mosaicing, in which consecutive video frames acquired with a high resolution system are stitched together as the probe is advanced along the tissue. This is can be especially useful for visualizing the extent of a lesion and giving a broader sense of the overall tissue morphology. Video mosaicing can allow a clinician to acquire high resolution images from areas approximately 2 -30x larger than one single field of view [38, 39] . While video mosaicing is a promising approach, current publications have only demonstrated its use in postprocessing.
There has also been a focus on developing targeted contrast agents to be used with high In an in vivo human trial, Hsiung et al. has demonstrated the use of a specific contrast agent that targets colonic dysplasia with pCLE. The contrast agent used was a fluorescently labeled heptapeptide sequence which was determined to specifically bind to areas of colonic dysplasia. In this study, polyps were first endoscopically identified. Following identification, the peptide was applied and then imaged with pCLE. A neighboring, normal region of mucosa was also imaged. Polyps imaged with pCLE were then biopsied and processed for histology.
Characteristic fluorescence images of the colon are displayed in Figure 5 . As can be seen, the contrast agent primarily binds to the dysplastic crypts, while the normal crypts are unlabeled. A total of 18 polyps were imaged with 5 representative images selected for each polyp. Analysis of the acquired images consisted of comparison of the mean fluorescence intensity between normal mucosa and the adenoma in three 25 x 25 µm regions of interest for each image acquired, yielding a total of 270 different regions of interest. This resulted in a sensitivity and specificity of 81% and 82%, respectively, when comparing the mean fluorescence intensity between normal tissue and adenomas [40] . Figure 6J and 6K, and are fused in Figure 6L , showing that the polyps exhibit higher scattering coefficients and fluorescence intensities than the surrounding tissue.
In other work, Iftimia et al. demonstrated co-registered ex vivo widefield fluorescence imaging and OCT using colon tissue from ApcMin mice [50] . Fluorescence imaging was achieved using poly(epsilon-caprolactone) microparticles labeled with a NIR dye and functionalized with an RGD (argenine-glycine-aspartic acid) peptide to recognize the over expression of ανβ3 integrin receptor (ABIR). Winkler et al. combined OCT and fluorescence microscopy in vivo via endoscope using the azoxymethane-treated mouse model of colon cancer [51] . Fluorescence was achieved using the conjugation of a near-infrared fluorescent dye, Cy5.5, to single chain vascular endothelial growth factor. The combination of OCT and spectroscopy has also been investigated by Robles et al. , who demonstrated the combination of both techniques using a source in the visible domain [52] . 
Conclusion
The need to improve the detection and classification of early stage neoplasia in the esophagus and colon has led to the development of a variety of widefield and high resolution optical imaging techniques. While some widefield techniques, such as AFI and NBI, do not require the application of contrast agents, these techniques and others could potentially be enhanced by the use of contrast agents that specifically highlight biochemical changes associated with neoplasia. Widefield fluorescence and high resolution imaging such as confocal laser endomicroscopy and OCT can combine molecular and morphological imaging to yield information about the structure and nature of the tissue. Of specific note are the recent advancements in targeted contrast agents, which have been used to highlight areas of dysplasia.
While promising, there are a number of challenges that must be solved before large scale implementation of optical molecular imaging can be achieved. First, larger scale, multi-central studies are required with appropriate histologic endpoints to properly assess the diagnostic potential of each modality. In cases where commercial instruments are not yet available, additional effort is required to ensure standardization of imaging platforms. In the longer term, further study is required to examine whether the use of new modalities has a positive impact on patient outcomes. There are additional barriers to the implementation of approaches that rely on targeted contrast agents, including the identification of biomarkers which are sufficiently and consistently upregulated in neoplasia, the development of appropriate delivery formulations, and navigation of complex regulatory barriers.
